Method for infusing insulin to a subject to improve impaired total body tissue glucose processing

• US 20060122099A1
• Filed: 12/08/2004
• Published: 06/08/2006
• Est. Priority Date: 12/08/2004
• Status: Abandoned Application

• Current Assignee: Thomas T. Aoki
• Original Assignee: Thomas T. Aoki
• Inventors: Aoki, Thomas T.
• Application Number:
  US11/007,390
• Publication Number:
  US 20060122099A1
• Time in Patent Office: Days
• US Class Current: 514/5.900
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/4088 Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
• CPC Class Codes: A61K 38/28 Insulins
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00

Abstract

The present invention is a method for delivering insulin to a subject to improve impaired total body tissue glucose processing. The method delivers one or more pulses of insulin to the subject over a period of time accompanied by ingestion of glucose in the form of a carbohydrate containing meal. The number of pulses, the amount of insulin in each pulse, the interval between pulses and the amount of time to deliver each pulse to the subject are selected so that total body tissue processing of glucose is restored in the subject. In subjects whose total body tissue glucose processing has been restored there is a subsequent fall in circulating blood glucose levels of 50 mg/dl or more directly as a result of improved total body tissue glucose processing.

Claims

1. A method for infusing insulin to a subject to improve impaired total body tissue glucose processing comprising the steps of:

a. determining a steady baseline circulating glucose level of the subject and obtaining a subsequent circulating glucose level at least every 30 minutes, the steady baseline circulating glucose level being two consecutive circulating glucose levels about 200 milligrams per deciliter measured five minutes apart,

b. having the subject ingest a carbohydrate containing meal,

c. administering a quantity of insulin through an intravenous site until the subsequent circulating glucose level shows an improvement over the steady baseline circulating glucose level, the improvement over the steady baseline circulating glucose level being a 50 milligram per deciliter or more fall in the steady baseline circulating glucose level within approximately two hours of administering the quantity of insulin, the subsequent circulating glucose level improvement over the steady baseline circulating glucose level being a measurement of sufficient quantity of insulin to achieve an improvement in total body tissue glucose processing,

wherein the improvement in total body tissue glucose processing occurs as a result of total body tissue response to a rate of change in insulin level and an absolute increase in peak and interpeak free insulin levels,

d. allowing the subject to rest at least one hour,

e. repeating steps a-d at least two times.

2. The method of claim 1, wherein the carbohydrate containing meal contains 40 to 100 grams of glucose.

3. The method of claim 1 wherein the intravenous site further comprises a needle or catheter located in the subject'"'"'s body, hand or forearm.

4. The method of claim 1, wherein the quantity of insulin contains 10 to 200 milliunits of insulin per kilogram of body weight.

5. The method of claim 1, wherein the quantity of insulin is delivered every 3 to 30 minutes.

6. The method of claim 1, wherein the quantity of insulin is delivered as a series of pulses.

7. The method of claim 1, wherein the quantity of insulin is administered by an intravenous infusion device.

8. The method of claim 1, wherein the quantity of insulin is administered by a syringe.

9. The method of claim 1, wherein the intravenous site is converted to a heparin or saline lock when allowing the subject to rest.

10. The method of claim 1, wherein said steps a-e are repeated at least one a week.

11. The method of claim 1, wherein said steps a-e are repeated three or more time a week.

12. The method of claim 1, wherein the improvement in total body tissue glucose processing is used to lower levels of hemoglobin A1c.

13. The method of claim 1, wherein the improvement in total body tissue glucose processing is used to delay the onset or slow the progression of diabetes related nephropathy.

14. The method of claim 1, wherein the improvement in total body tissue glucose processing is used to delay the onset or slow the progression of diabetes related retinopathy.

15. The method of claim 1, wherein the improvement in total body tissue glucose processing is used to delay the onset or slow the progression of diabetes related neuropathy.

16. The method of claim 1, wherein the improvement in total body tissue glucose processing is used to delay the onset or slow the progression of cardiovascular disease.

17. The method of claim 1, wherein the improvement in total body tissue glucose processing is used to delay the onset or slow the progression of heart disease.

18. The method of claim 1, wherein the improvement in total body tissue glucose processing is used for treating wounds, promoting healing and avoiding amputations in diabetic subjects.

19. The method of claim 1, wherein the improvement in total body tissue glucose processing is used to improve mental function in subjects with senile dementia.

20. The method of claim 1, wherein the improvement in total body tissue glucose processing is used to improve mental function in subjects having a decreased glucose oxidation rate due to aging, brain injury, brain trauma or jet lag.